The BCR is a surface receptor crucial for antigen recognition and B cell proliferation in the normal physiologic context, while in CLL, the BCR pathway is often constitutively activated (Figure 1) [6]. This evidence concerns the gene BCR and B-cell chronic lymphocytic leukemia.